Table 1.
Parameter | RAS-group | OS-group | P |
---|---|---|---|
Mean age, years (range) | 58.7±13.7 (32–78) | 65.3±12.9 (34–78) | 0.07 |
Male: Female (%) | 4:21 (16:84) | 13:12 (52:48) | <0.05 |
Mean BMI, kg/m2 (range) | 25.2±4.5 (14.9–37) | 23.9±3.7 (17.9–31.3) | 0.24 |
ASA score, n (%) | |||
ASA I | 1 (4) | 0 | 0.31 |
ASA II | 11 (44) | 9 (36) | 0.57 |
ASA III | 12 (48) | 14 (56) | 0.59 |
ASA IV | 1 (4) | 2 (8) | 0.55 |
Previous abdominal surgery, n (%) | 12 (48) | 14 (58) | 0.59 |
Co-morbidity, n (%) | |||
Diabetes | 4 (16) | 3 (12) | 0.72 |
Cardiopulmonary disease | 14 (56) | 16 (64) | 0.58 |
Pre-operative diagnosis | |||
Mucinous cystadenoma, n (%) | 13 (48.1) | 16 (59.3) | 0.41 |
Brach-duct IPMN, n (%) | 5 (18.5) | 3 (11.1) | 0.44 |
Oligocystic lesions with high risk features of uncertain aetiology, n (%) | 9 (33.3) | 8 (29.6) | 0.84 |
BMI: Body mass index, ASA: American Society of Anesthesiologists, OS: Open surgery, IPMN: Intraductal papillary mucinous neoplasms, RAS: Robotic-assisted surgery